Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide. Inconsistency in various histo-pathologic features for predicting nodal metastasis and overall prognosis and a better understanding of molecular mechanisms of tumourigenesis have shifted the focus to a search for more definitive predictive markers. To identify the role of two immunohistochemical (IHC) markers, E-cadherin and cyclin D1, as predictive markers of aggressiveness in HNSCC and to assess clonal expansion of tumour cells. Materials and Methods: A total of 66 cases of HNSCC with neck node dissection were studied. IHC was performed on primary tumour sections and lymph nodes showing metastatic deposits. Histopathological parameters such as tumour grade and TNM stage together with nodal status were compared according to expression of the two markers. Fischer’s chi-square test was used to assess the correlation between the two markers and histo-pathological parameters. Results: Out of 66 cases studied, 37 showed LN metastasis. Most of the patients were male, and the most common tumour site was buccal mucosa. We found a significant association between loss of E-cadherin and node metastasis (P<0.001) and higher TNM stage (P<0.001). Cyclin D1 overexpres-sion was significantly associated with only nodal metastasis (P=0.007). No significant association with tumour grade was found for either marker. The subgroup of E-cadherin loss with cyclin D1 overexpression was associated with the maximum incidence of nodal metastasis and higher TNM stage, highlighting the importance of using a combination of these two markers. A significant association was noted between the expression of markers at the primary site and at nodal deposits, indicating clonal expansion. Conclusion: A combination of the two markers E-cadherin and cyclin D1 can predict prognosis in HNSCC, although tumour heterogeneity may af-fect this association in some cases.
Abstract
Objectives: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide. Inconsistency in various histo-pathologic features for predicting nodal metastasis and overall prognosis and a better understanding of molecular mechanisms of tumourigenesis have shifted the focus to a search for more definitive predictive markers. To identify the role of two immunohistochemical (IHC) markers, E-cadherin and cyclin D1, as predictive markers of aggressiveness in HNSCC and to assess clonal expansion of tumour cells. Materials and Methods: A total of 66 cases of HNSCC with neck node dissection were studied. IHC was performed on primary tumour sections and lymph nodes showing metastatic deposits. Histopathological parameters such as tumour grade and TNM stage together with nodal status were compared according to expression of the two markers. Fischer’s chi-square test was used to assess the correlation between the two markers and histo-pathological parameters. Results: Out of 66 cases studied, 37 showed LN metastasis. Most of the patients were male, and the most common tumour site was buccal mucosa. We found a significant association between loss of E-cadherin and node metastasis (P<0.001) and higher TNM stage (P<0.001). Cyclin D1 overexpres-sion was significantly associated with only nodal metastasis (P=0.007). No significant association with tumour grade was found for either marker. The subgroup of E-cadherin loss with cyclin D1 overexpression was associated with the maximum incidence of nodal metastasis and higher TNM stage, highlighting the importance of using a combination of these two markers. A significant association was noted between the expression of markers at the primary site and at nodal deposits, indicating clonal expansion. Conclusion: A combination of the two markers E-cadherin and cyclin D1 can predict prognosis in HNSCC, although tumour heterogeneity may af-fect this association in some cases.
참고문헌 (46)
- Mehendiratta M, "Clinico-pathological correlation of E-cadherin expression at the invasive tumor front of Indian oral squamous cell carcinomas: an immunohistochemical study", J Oral Maxillofac Pathol, 18, pp.217~222 (2014)[DOI]
- Iglesias-Bartolome R, "Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets", Cancer Discov, 3, pp.722~725 (2013)[DOI]
- Parkin DM, "Estimating the world cancer burden: Globocan 2000", Int J Cancer, 94, pp.153~156 (2001)[DOI]
- Xu Y, "Role of met axis in head and neck cancer", Cancers (Basel), 5, pp.1601~1618 (2013)[DOI]
- Eiband JD, "Prognostic factors in squamous cell carcinoma of the larynx", Am J Surg, 158, pp.314~317 (1989)[DOI]
- Tytor M, "Prognostic factors in oral cavity carcinomas", Acta Otolaryngol Suppl, 492, pp.75~78 (1992)
- Stelow EB, "Squamous cell carcinoma variants of the upper aerodigestive tract", Am J Clin Pathol, 124(Suppl), pp.S96~S109 (2005)
- Noguchi M, "Prognostic factors and relative risk for survival in N1-3 oral squamous cell carcinoma: a multivariate analysis using Cox's hazard model", Br J Oral Maxillofac Surg, 37, pp.433~437 (1999)[DOI]
- Rahima B, "Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 97, pp.423~431 (2004)[DOI]
- Woolgar JA, "Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread", Oral Oncol, 39, pp.130~137 (2003)[DOI]
- Puri SK, "Significance of extracapsular lymph node metastases in patients with head and neck squamous cell carcinoma", Curr Opin Otolaryngol Head Neck Surg, 11, pp.119~123 (2003)[DOI]
- Shingaki S, "Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas", Am J Surg, 185, pp.278~284 (2003)[DOI]
- Close LG, "Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx", Head Neck, 11, pp.309~317 (1989)[DOI]
- van den Brekel MW, "Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study", Eur Arch Otorhinolaryngol, 250, pp.11~17 (1993)[DOI]
- Takes RP, "Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer", J Pathol, 194, pp.298~302 (2001)[DOI]
- Fidler IJ, "Biological diversity in metastatic neoplasms: origins and implications", Science, 217, pp.998~1003 (1982)[DOI]
- Lengauer C, "Genetic instabilities in human cancers", Nature, 396, pp.643~649 (1998)[DOI]
- Cortesina G, "Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature", Acta Otorhinolaryngol Ital, 26, pp.317~325 (2006)
- Belbin TJ, "Molecular profiling of tumor progression in head and neck cancer", Arch Otolaryngol Head Neck Surg, 131, pp.10~18 (2005)[DOI]
- Ren X, "E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations", Onco Targets Ther, 9, pp.2447~2453 (2016)
- Chaw SY, "Epithelial to mesenchymal transition (EMT) biomarkers--Ecadherin, beta-catenin, APC and vimentin--in oral squamous cell carcinogenesis and transformation", Oral Oncol, 48, pp.997~1006 (2012)[DOI]
- Rodrigo JP, "Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features", Eur J Cancer, 38, pp.1059~1064 (2002)[DOI]
- Yokoyama K, "Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro", Oral Oncol, 37, pp.65~71 (2001)[DOI]
- Suh Y, "Clinical update on cancer: molecular oncology of head and neck cancer", Cell Death Dis, 5, pp.e1018~ (2014)[DOI]
- Lin RJ, "Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer", J Otolaryngol Head Neck Surg, 42, pp.23~ (2013)[DOI]
- Gotte M, "An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ", Breast Cancer Res, 9, pp.R8~ (2007)[DOI]
- Scantlebury JB, "Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status", Hum Pathol, 44, pp.1672~1680 (2013)[DOI]
- 도남용, "The Role of E-cadherin", β-catenin Complex and Cyclin D1 in Head and Neck Squamous Cell Carcinoma, 2004, pp.36(1), 72~78[DOI]
- Ahmed RA, "Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma", Pathol Oncol Res, 20, pp.625~633 (2014)[DOI]
- Takes RP, "Markers for nodal metastasis in head and neck squamous cell cancer", Arch Otolaryngol Head Neck Surg, 128, pp.512~518 (2002)[DOI]
- Suresh TN, "Evaluation of histomorphological and immunohistochemical parameters as biomarkers of cervical lymph node metastasis in squamous cell carcinoma of oral cavity: a retrospective study", J Oral Maxillofac Pathol, 19, pp.18~24 (2015)[DOI]
- Jiang WG, "E-cadherin and its associated protein catenins, cancer invasion and metastasis", Br J Surg, 83, pp.437~446 (1996)[DOI]
- Akhtar K, "Diagnostic and prognostic significance of E-cadherin and vimentin in oral cancer metastasis", Ann Pathol Lab Med, 3, pp.A8~A13 (2016)
- Kaur G, "Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study", Indian J Dent Res, 20, pp.71~76 (2009)[DOI]
- Balasundaram P, "Study of <TEX>${\beta}$<", TEX>-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases, 2014, pp.9, 145~
- Wang MB, "Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin", Laryngoscope, 111, pp.982~988 (2001)[DOI]
- Mattijssen V, "E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome", Int J Cancer, 55, pp.580~585 (1993)[DOI]
- Bankfalvi A, "Deranged expression of the E-cadherin", beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas, 2002, pp.31, 450~457
- Shinohara M, "Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour", J Pathol, 184, pp.369~381 (1998)[DOI]
- Carlos de Vicente J, "Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance", Oral Oncol, 38, pp.301~308 (2002)[DOI]
- Das SN, "Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobaccorelated intraoral squamous cell carcinoma", Indian J Med Res, 133, pp.381~386 (2011)
- Dhingra V, "Evaluation of cyclin D1 expression in head and neck squamous cell carcinoma", J Clin Diagn Res, 11, pp.EC1~EC4 (2017)[DOI]
- Michalides RJ, "Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck", Arch Otolaryngol Head Neck Surg, 123, pp.497~502 (1997)[DOI]
- Zhao Y, "Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis", PLoS One, 9, pp.e93210~ (2014)[DOI]
- Saawarn S, "Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma", Scientific-WorldJournal, 2012, pp.978327~ (2012)
- Sunit B. Patel, "Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia", 대한구강악안면외과학회지, 43(5), pp.324~330 (2017), 대한구강악안면외과학회
